The asymmetric unit of the title compound, C 34 H 38 N 3 O 7 PÁ0.5C 3 H 6 O {systematic name: (RS)-2-[phenyl(phenylmethyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3-dioxa-2 5 -phosphacyclohex-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate acetone hemisolvate}, contains one R-efonidipine molecule, one S-efonidipine molecule and half of a solvate acetone molecule. In both efonidipine molecules, the six-membered rings of the dioxaphosphinanyl moieties display a chair conformation and the dihydropyridine rings display a flattened boat conformation. In the crystal, N-HÁ Á ÁO, C-HÁ Á ÁO hydrogen bonds and weak C-HÁ Á Á interactions link the molecules into a threedimensional supramolecular structure. A solvent-accessible void of 199 Å 3 is found in the structure; the contribution of the heavily disordered solvate molecule was suppressed by use of the SQUEEZE routine in PLATON [Spek (2015). Acta Cryst. C71, 9-18].
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Structure description (RS)-Efonidipine is an efficient and long-acting Ca
2+ channel blocker with renal protection, and has been used clinically in Japan and Korea (Yamashita et al., 1991; Saito et al., 1992) . (S)-efonidipine has been synthesized by asymmetric synthesis and its crystal structure reported in the space group P2 1 2 1 2 1 (Guo et al., 2008; Sakoda et al., 1992) . Here we report the crystal structure of (RS)-efonidipine acetone hemisolvate. For the structure of an efonidipine analogue, 1,2,3,4,5,6,7,8-octahydro-3,3,6,6-tetramethyl-9 -(2-nitrophenyl)xanthene-1,8-dione, see : Jeyakanthan et al. (1999) .
As shown in Fig. 1 , the asymmetric unit of the title compound contains a (R)-efonidipine molecule, a (S)-efonidipine molecule and half of an acetone molecule. In both efonidipine molecules, the six-membered rings of the dioxaphosphinanyl moieties display data reports a chair conformation and the dihydropyridine rings display a flattened boat conformation.
In the crystal, classical N-HÁ Á ÁO hydrogen bonds and weak C-HÁ Á ÁO and C-HÁ Á Á interactions (Table 1) link the molecules into a three-dimensional network.
Synthesis and crystallization
(RS)-Efonidipine was prepared using a Hantzsch pyridine reaction, starting with two intermediates I {2-butenoic acid, 3-amino-2-[phenyl(phenylmethyl)amino] ethyl ester} and II {3-buten-2-one, 3-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-4-(3-nitrophenyl)}. The intermediates I (7.0 g, 22.55 mmol) and II (7.6 g, 22.40 mmol) were dissolved in 150 ml of 2-propanol at 83 C with reflux, stirred for 3 h, then cooled down to room temperature and stirred for 8 h, vacuum filtration, recrystallized in 100 ml of ethanol, vacuum drying, yield 11.05 g (78.09%). Slow evaporation of a solution in acetone while left to stand for 4 days gave light-yellow rhombus-shaped columnar crystals.
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . The solvent-accessible void of 199 Å 3 is found in the structure, the presumed contribution of a heavily disordered solvate molecule was suppressed by the SQUEEZE routine in PLATON (Spek, 2015) . Table 1 Hydrogen-bond geometry (Å , ).
Cg4 and Cg9 are the centroids of the C22 0 -C27 0 and C22-C27 rings, respectively. Computer programs: CrysAlis PRO (Agilent, 2014), SHELXS (Sheldrick, 2008) , SHELXL (Sheldrick, 2015) and OLEX2 (Dolomanov et al., 2009).
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Figure 1
The molecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level.
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Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
